Revolutionizing Health: Cambridge Firm Innovates COVID Cure with Cutting-Edge AI Technology
Cambridge-based AI VIVO, a pioneering company at the intersection of artificial intelligence and systems pharmacology, is actively seeking partnerships with biotech and pharmaceutical firms to advance the promising candidate drugs it has identified as potential treatments for Covid-19. The company employs an innovative phenotypic drug discovery approach that operates independently of pre-existing knowledge about the…